Latest Angiogenesis Stories
LONDON, June 25, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
Pioneering Angiogenic Gene Therapy for the Potential Treatment of Millions of Patients with Heart Disease Worldwide SAN DIEGO, June 24, 2014 /PRNewswire/ -- Taxus Cardium Pharmaceuticals
MUMBAI, June 20, 2014 /PRNewswire/ -- Cytokines, a major group in the protein therapeutics umbrella, are known to be soluble extracellular proteins or glycoproteins which
SAN DIEGO, June 12, 2014 /PRNewswire/ -- Taxus Cardium Pharmaceuticals Group Inc.
INDIANAPOLIS, June 11, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that the Phase III REACH trial of CYRAMZA(TM) (ramucirumab) in patients with hepatocellular carcinoma,
Two New Therapies Will Match Progression-Free Survival Improvements Required By Surveyed U.S.
-- REVEL Data Published in The Lancet, Presented at Annual ASCO Meeting -- CHICAGO, June 2, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced detailed results from REVEL,
COMBO(TM) Dual Therapy Stent shown to actively promote rapid endothelialization and deliver long-term, true vessel healing HONG KONG, May 23, 2014 /PRNewswire/ --
Mechanisms of VEGF inhibitor-induced hypertension need to be better understood and guidelines developed to improve management.
MARIETTA, Ga., May 6, 2014 /PRNewswire/ -- MiMedx Group, Inc.
- The parings of haberdine; also, any kind of fragments.